The key observations in our study confirm and extend the current understanding of how the immune system is regulated during tumorigenesis and emphasize the importance of the immune microenvironments of the tumor, spleen, and TDLN and the roles played by IL-10 and TGF-β in regulating Nrp-1-derived Tregs during this process. The gene discussed is NRP1; the disease is neoplasm.